A phase II study of ramucirumab for advanced, pre-treated biliary cancers.

被引：2
|
作者：
Mizrahi, Jonathan
Javle, Milind M.
Xiao, Lianchun
Varadhachary, Gauri R.
Raghav, Kanwal Pratap Singh
Wolff, Robert A.
Shroff, Rachna T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4081
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4081
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study
    Williams, Kerry J.
    Picus, Joel
    Trinkhaus, Kim
    Fournier, Chloe C.
    Suresh, Rama
    James, Joan S.
    Tan, Benjamin R.
    HPB, 2010, 12 (06) : 418 - 426
  • [22] Randomized phase II trial of trifluridine/tipiracil plus ramucirumab versus trifluridine/tipiracil for pre-treated patients with advanced gastric or gastroesophageal junction adenocarcinoma (RETRIEVE study, WJOG15822G)
    Takahashi, N.
    Hara, H.
    Nagashima, K.
    Hirata, K.
    Masuishi, T.
    Matsumoto, T.
    Kawakami, H.
    Yamazaki, K.
    Hironaka, S.
    Boku, N.
    Muro, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S198 - S198
  • [23] A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.
    Blagden, Sarah Patricia
    Rizzuto, Ivana
    Stavraka, Chara
    O'Shea, Daniel
    Suppiah, Puvan
    Patel, Markand
    Loyse, Naomi
    Sukumaran, Ajithkumar
    Bharwani, Nishat
    Rockall, Andrea
    Gabra, Hani
    El-Bahrawy, Mona
    Wasan, Harpreet S.
    Leonard, Robert C. F.
    Habib, Nagy A.
    McGuigan, Christopher
    Gribben, John G.
    Ghazaly, Essam Ahmed
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers.
    Javle, Milind M.
    Bridgewater, John A.
    Gbolahan, Olumide B.
    Jungels, Christiane
    Cho, May Thet
    Papadopoulos, Kyriakos P.
    Thistlethwaite, Fiona C.
    Canon, Jean-Luc Re
    Cheng Lulu
    Ioannidis, Sonia
    Gogov, Sven
    Aung, Naing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [25] Phase 2 study of carfilzomib for the treatment of patients with advanced neuroendocrine cancers.
    Singh, Jaswinder
    Shipley, Dianna
    Cultrera, Jennifer
    Chua, Cynthia
    Cohn, Allen Lee
    Soriano, Andres O.
    Bendell, Johanna C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [26] Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study
    Stathopoulos, GP
    Tsavdaridis, D
    Malamos, NA
    Rigatos, SK
    Kosmas, C
    Pergantas, N
    Stathopoulos, JG
    Xynotroulas, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (05) : 487 - 491
  • [27] Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer
    Seo, Hee Yeon
    Lee, Hyun Joo
    Woo, Ok Hee
    Park, Kyong Hwa
    Woo, Sang Uk
    Yang, Dae Sik
    Kim, Ae-Ree
    Lee, Jae-Bok
    Lee, Eun Sook
    Kim, Yeul Hong
    Kim, Jun Suk
    Seo, Jae Hong
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (02) : 360 - 365
  • [28] Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer
    Hee Yeon Seo
    Hyun Joo Lee
    Ok Hee Woo
    Kyong Hwa Park
    Sang Uk Woo
    Dae Sik Yang
    Ae-Ree Kim
    Jae-Bok Lee
    Eun Sook Lee
    Yeul Hong Kim
    Jun Suk Kim
    Jae Hong Seo
    Investigational New Drugs, 2011, 29 : 360 - 365
  • [29] Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study
    G. P. Stathopoulos
    D. Tsavdaridis
    N. A. Malamos
    S. K. Rigatos
    Ch. Kosmas
    N. Pergantas
    J. G. Stathopoulos
    J. Xynotroulas
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 487 - 491
  • [30] A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201)
    Bando, Hideaki
    Doi, Toshihiko
    Muro, Kei
    Yasui, Hirofumi
    Nishina, Tomohiro
    Yamaguchi, Kensei
    Takahashi, Shunji
    Nomura, Shogo
    Kuno, Hirofumi
    Shitara, Kohei
    Sato, Akihiro
    Ohtsu, Atsushi
    EUROPEAN JOURNAL OF CANCER, 2016, 62 : 46 - 53
12345